Leveraging its deep expertise in artificial intelligence and machine learning, Amii will apply AI to combine socio-demographic, medical and non-medical data to identify patients at higher risk of developing post-treatment complications. The resulting intelligent insights will allow healthcare teams to provide proactive, personalized care, while educating patients on actions they can take to reduce the risk of adverse events. Overall, the project is expected to improve recovery outcomes, particularly for patients in rural or remote communities.

“This project shows how AI can address urgent and complex health care challenges, and apply solutions in a way we’ve never been able to do before,” says Marlene McNaughton, Amii’s Chief Revenue Officer. “Through our collaboration, Zamplo will be able to advance predictive ML models to help clinicians, caregivers, and community stakeholders proactively identify patients at higher risk of an adverse event, preventing emergency room visits before they happen and delivering truly personalized, proactive care."

“Since our founding, Zamplo has been committed to bridging the gap between healthcare and home to increase patient engagement and improve outcomes, while supporting improved clinical care,” says Zamplo Chief Executive Officer Mike Urquhart. “What sets this project apart is the ability to securely and privately gather data directly from patients, and share the explainable ML model results back to them so that they have agency over their own health.”

While a life-saving treatment for over half of all cancer patients, radiation therapy may cause life-altering adverse effects, from a reduced quality of life to long-term and even life-threatening complications. A recently published study of more than 15,000 radiation therapy patients treated at University Health Network (UHN) shows that a significant number of recovery patients required unplanned follow-up within the first 90 days of treatment. This project will address the urgent need to move away from a "one-size-fits-all" approach to a more personalized and proactive form of radiation therapy.

“After radiation therapy, the first 90 days are critical,” says Phillip Wong, Clinical Investigator, UHN’s Princess Margaret Cancer Centre. “Many patients face complications that bring them back to the hospital unexpectedly. This initiative will help clinicians identify those at higher risk sooner and take earlier action to support recovery—potentially preventing an emergency visit altogether.”